Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112

Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology

Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028

Apolipoprotein E polymorphism and atherosclerosis.

Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981

Plasma lipoproteins: apolipoprotein structure and function.

Mahley, R. W., Innerarity, T. L., Rall, S. C., & Weisgraber, K. H. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34443-6 · Cited by 1,155

Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.

Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52510-8 · Cited by 777

Lipoprotein receptors and cholesterol homeostasis

Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 756

Human apolipoprotein E. The complete amino acid sequence

Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741

Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.

Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113243 · Cited by 418

Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations.

Ehnholm, C., Lukka, M., Kuusi, T., Nikkilä, E. A., & Utermann, G. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38833-7 · Cited by 403

Abnormal in vivo metabolism of apolipoprotein E4 in humans.

Gregg, R. E., Zech, L. A., Schaefer, E. J., Stark, D., Wilson, D., & Brewer, H. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112645 · Cited by 345

Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains.

Wetterau, J. R., Aggerbeck, L. P., Rall, S. C., & Weisgraber, K. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68778-2 · Cited by 293

Effect of apolipoprotein E gene Hha I restricting fragment length polymorphism on serum lipids in cholecystolithiasis

Lin, Q. (1999) · World Journal of Gastroenterology · doi:10.3748/wjg.v5.i3.228 · Cited by 16

Regulated turnover of a cell surface-associated pool of newly synthesized apolipoprotein E in HepG2 cells

Schmitt, M., & Grand-Perret, T. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33337-x · Cited by 14

Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotype

Luc, G., Ducimetière, P., Bard, J., Arveiler, D., Evans, A., Cambien, F., Fruchart, J., & Fiévet, C. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00053-1 · Cited by 16

Apolipoprotein E Levels in the Cerebrospinal Fluid of North Indian Patients With Alzheimer’s Disease

Kandimalla, R. J. L., Wani, W. Y., Anand, R., Kaushal, A., Prabhakar, S. K., Grover, V. K., Bharadwaj, N., Jain, K., & Gill, K. D. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513481097 · Cited by 15

Is Apolipoprotien E codon 112 Polymorphisms Associated with Recurrent Pregnancy Loss?

Özörnek, H., Ergin, E., Jeyendran, R. S., Özay, A., Pillai, D., & Coulam, C. B. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00814.x · Cited by 15

Structural Characterization of a Low Density Lipoprotein Receptor-active Apolipoprotein E Peptide, ApoE3-(126–183)

Raussens, V., Mah, M. K. H., Kay, C. M., Sykes, B. D., & Ryan, R. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005732200 · Cited by 15

Influence of macrophage-derived apoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apoprotein E-deficient mice

Spangenberg, J., & Curtiss, L. K. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00123-9 · Cited by 15

Alzheimer’s Disease: Causal Effect between Obesity and APOE Gene Polymorphisms

Zhao, T., Zhong, T., Zhang, M., Xu, Y., Zhang, M., & Chen, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713531 · Cited by 14

Isolation of subpopulations of high density lipoproteins: three particle species containing apoE and two species devoid of apoE that have affinity for heparin

Hennessy, L. K., Kunitake, S. T., Jarvis, M., Hamilton, R. L., Endeman, G., Protter, A. A., & Kane, J. P. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37160-1 · Cited by 14

Postprandial apoE Isoform and Conformational Changes Associated with VLDL Lipolysis Products Modulate Monocyte Inflammation

den Hartigh, L. J., Altman, R., Hutchinson, R., Petrlová, J., Budamagunta, M. S., Tetali, S. D., Lagerstedt, J. O., Voss, J. C., & Rutledge, J. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050513 · Cited by 14

Hidden Aggregation Hot-Spots on Human Apolipoprotein E: A Structural Study

Tsiolaki, P. L., Katsafana, A. D., Baltoumas, F. A., Louros, N. N., & Iconomidou, V. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092274 · Cited by 15

Dietary fish oil-induced decrease in low density lipoprotein binding to fibroblasts is mediated by apolipoprotein E.

Linga, V., Leight, M. A., Curtiss, L. K., Marcel, Y. L., Clair, R. W. S., & Parks, J. S. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41200-3 · Cited by 14

Redox status of serum apolipoprotein E and its impact on HDL cholesterol levels

Yamauchi, K., Ebihara, Y., & Kawakami, Y. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.03.021 · Cited by 13

C-terminal interactions of apolipoprotein E4 respond to the postprandial state

Tetali, S. D., Budamagunta, M. S., Voss, J. C., & Rutledge, J. C. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500559-jlr200 · Cited by 13

Impact of the Apolipoprotein E (epsilon) Genotype on Cardiometabolic Risk Markers and Responsiveness to Acute and Chronic Dietary Fat Manipulation

Rathnayake, K. M., Weech, M., Jackson, K. G., & Lovegrove, J. A. (2019) · Nutrients · doi:10.3390/nu11092044 · Cited by 12

Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4

Vezeridis, A. M., Drosatos, K., & Zannis, V. I. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m008409 · Cited by 11

Curious Dichotomies of Apolipoprotein E Function in Alzheimer’s Disease and Cancer—One Explanatory Mechanism of Inverse Disease Associations?

Perks, C. M., Barker, R. M., Alhadrami, M., Alkahtani, O., Gill, E., Grishaw, M., Harland, A. J., Henley, P., Li, H., O’Sullivan, E., et al. (2025) · Genes · doi:10.3390/genes16030331 · Cited by 11

Properties of apolipoprotein E derived peptide modulate their lipid-binding capacity and influence their anti-inflammatory function

Nankar, S. A., & Pande, A. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.01.006 · Cited by 11

Human apolipoprotein E7: lysine mutations in the carboxy-terminal domain are directly responsible for preferential binding to very low density lipoproteins

Dong, J., Balestra, M. E., Newhouse, Y. M., & Weisgraber, K. H. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31971-4 · Cited by 11

Successful Gene Editing of Apolipoprotein E4 to E3 in Brain of Alzheimer Model Mice After a Single IV Dose of Synthetic Exosome-Delivered CRISPRPreprint

Teter, B., Campagna, J. J., Zhu, C., McAuley, G. E., Spilman, P. R., Kohn, D. B., & John, V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.23.590784 · Cited by 12

Effects of DHA (omega-3 fatty acid) and estradiol on amyloid β-peptide regulation in the brain

Majou, D., & Dermenghem, A.-L. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148681 · Cited by 10

MAD—microbial (origin of) Alzheimer’s disease hypothesis: from infection and the antimicrobial response to disruption of key copper-based systems

Min, J.-H., Sarlus, H., & Harris, R. A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1467333 · Cited by 11

The redox status of cysteine thiol residues of apolipoprotein E impacts on its lipid interactions

Yamauchi, K., & Kawakami, Y. (2020) · Biological Chemistry · doi:10.1515/hsz-2019-0414 · Cited by 10

Innate immune responses to HIV infection in the central nervous system

Geffin, R., & McCarthy, M. (2013) · Immunologic Research · doi:10.1007/s12026-013-8445-4 · Cited by 10

Protein-Ligand Interactions

Gordon, S. E., & Perugini, M. A. (2016) · Springer eBooks · doi:10.1007/978-4-431-55985-6_16 · Cited by 10

Crystal Structures of the Common Apolipoprotein E Variants: Insights into Functional Mechanisms

Wardell, M. R., Wilson, C., Agard, D. A., Mahley, R. W., & Weisgraber, K. H. (1993) · Springer eBooks · doi:10.1007/978-3-642-84634-2_8 · Cited by 10

The current state of apolipoprotein E in dyslipidemia

Rasmussen, K. L., & Frikke‐Schmidt, R. (2023) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000915 · Cited by 11

Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects

Corsetti, J. P., Sparks, C. E., Bakker, S. J. L., Gruppen, E. G., & Dullaart, R. P. F. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.11.010 · Cited by 9

A Biophysical Approach to the Identification of Novel ApoE Chemical Probes

Kraft, L., Serpell, L. C., & Atack, J. R. (2019) · Biomolecules · doi:10.3390/biom9020048 · Cited by 9

Low-Density Lipoprotein Particle Size Subfractions and Cerebral Amyloidosis

Lee, S., Parekh, T., King, S. M., Reed, B., Chui, H. C., Krauss, R. M., & Yassine, H. N. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181252 · Cited by 10

Effect of apolipoprotein E (apoE) phenotype on the apoE content of CSF-HDL in children

Hirayama, S., Miida, T., Obayashi, K., Yamazaki, F., Yamazaki-Sakurai, M., Ito, M., Saito, Y., Hanyu, O., Suzuki, K., & Aizawa, Y. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.01.004 · Cited by 9

Association of human apolipoprotein E with lipoproteins secreted by transfected McA RH7777 cells

Reardon, C. A., Blachowicz, L., Watson, K. M., Barr, E., & Getz, G. S. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32517-7 · Cited by 9

Polymorphisms of the apolipoprotein E gene affect response to atorvastatin therapy in acute ischemic stroke

Bi, Q., Zhou, X., Lu, Y., Wang, F., Wang, Y., Wang, F., & Wang, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1024014 · Cited by 8

Replacement of helix 1′ enhances the lipid binding activity of apoE3 N‐terminal domain

Redmond, K. A., Murphy, C., Narayanaswami, V., Kiss, R. S., Hauser, P. S., Guigard, E., Kay, C. M., & Ryan, R. O. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05089.x · Cited by 9

Recent insights into the pathogenesis of type III hyperlipoproteinemia

Fazio, S. (1993) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(93)90005-q · Cited by 8

Serum triglycerides in Alzheimer’s disease: Relation to neuroimaging and CSF biomarkersPreprint

Bernath, M. M., Bhattacharyya, S., Nho, K. T., Barupal, D. K., Fiehn, O., Baillie, R., Risacher, S. L., Arnold, M., Jacobson, T. Y., Trojanowski, J. Q., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/441394 · Cited by 8

Redox equilibrium of serum apolipoprotein E3: a buffering effect of disulfide-linked complexes against oxidative stress on apolipoprotein E3–containing lipoproteins

Yamauchi, K., Iwasaki, S., & Kawakami, Y. (2019) · Bioscience Reports · doi:10.1042/bsr20190184 · Cited by 7

A quantitative trait locus influences coordinated variation in measures of ApoB-containing lipoproteins

Rainwater, D. L., Mahaney, M. C., VandeBerg, J. L., Brush, G., Almasy, L. A., Blangero, J., Dyke, B., Hixson, J. E., Cole, S. A., & MacCluer, J. W. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.06.004 · Cited by 7

Ovarian somatic tissue rejuvenates circulating apolipoproteins and promotes cognitive health in postreproductive female mice

McCoy, N. D., Gawrys, S. P., Mackintosh, S. G., Byrum, S. D., Kosari, N., Zhou, A., Mansoor, M. A. M., Ikeno, Y., Isola, J. V. V., Stout, M. B., et al. (2025) · GeroScience · doi:10.1007/s11357-025-02019-4 · Cited by 7

APOE ε4 Allele-associated Alzheimer's disease risk is consistent with increased lifetime exposure to a neurotoxic process

Smith, C. J., & Ashford, J. W. (2017) · Journal of Systems and Integrative Neuroscience · doi:10.15761/jsin.1000168 · Cited by 6

Role of APOE in glaucoma

Yi, W., Lv, D., Sun, Y., Mu, J., & Lu, X. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149414 · Cited by 8

Role of leucine zipper motif in apoE3 N-terminal domain lipid binding activity

Yamamoto, T., & Ryan, R. O. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.07.006 · Cited by 7

Human apolipoprotein E N-terminal domain displacement of apolipophorin III from insect low density lipophorin creates a receptor-competent hybrid lipoprotein

Fisher, C. A., Kiss, R. S., Francis, G. A., Gao, P., & Ryan, R. O. (1999) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s0305-0491(99)00028-0 · Cited by 6

Apolipoprotein E Polymorphism and Atherosclerosis Risk

Dallongeville, J. (1994) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1130-0_19 · Cited by 6

APOE Genotype and Endothelial Biomarkers: Towards Personalized Cardiovascular Screening

Titolo, G., Morello, M., Caiazza, S., Luisi, E., Solimene, A., Serpico, C., D’Elia, S., Golino, P., Loffredo, F. S., Natale, F., et al. (2025) · Genes · doi:10.3390/genes16121494 · Cited by 5

Association between apolipoprotein E genotype and warfarin response during initial anticoagulation

He, S., Zhang, H., Cao, Y., Nian, F., Chen, H., Chen, W., Auchoybur, M. L., Yin, L., Tao, Z., Tang, S., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.095 · Cited by 5

Apolipoprotein E and Alzheimer’s Disease

Franceschini, G., Calabresi, L., Sirtori, C. R., Frisoni, G. B., Geroldi, C., Bianchetti, A., Trabucchi, M., & Govoni, S. M. (1995) · Medical science symposia series · doi:10.1007/978-94-011-0039-7_48 · Cited by 5

Apolipoprotein structure: crystal and models

Atkinson, D. (1992) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(92)90075-i · Cited by 5

Determination of Apolipoprotein E in High Density Lipoprotein Fraction by Immunofixation Method and Turbidimetric Immunoassay After Precipitation

Okamoto, Y., Tsujii, H., Haga, Y., Tanaka, S., & Nakano, H. (1994) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.1.23 · Cited by 5

Unveiling proteomic and peptide-level modifications in cerebrospinal fluid and plasma in normal cognitive aging

Kamalian, A., Shichkova, P., Tognetti, M., Below, C., Ho, S. G., Bruderer, R., Reiter, L., Feng, Y., Lutz, M. W., & Moghekar, A. (2025) · Communications Medicine · doi:10.1038/s43856-025-01183-0 · Cited by 5

Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans

Brodeur, M. R., Rhainds, D., Charpentier, D., Boulé, M., Mihalache-Avram, T., Mecteau, M., Brand, G., Pedneault-Gagnon, V., Fortier, A., Niesor, E. J., et al. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100316 · Cited by 4

SNP analysis of genes related to cholesterol metabolism and associated with late-onset Alzheimer’s disease

Kim, D., Gim, J., Mishra, A., Lee, K., Cho, Y., & Kim, H. (2017) · Genes & Genomics · doi:10.1007/s13258-017-0524-9 · Cited by 4

Familial Dysbetalipoproteinemia: A Genetically Heterogeneous Disease Caused by Mutations of the Ligand Apolipoprotein E

Vermeer, B. J., Frants, R. R., & Havekes, L. M. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12462212 · Cited by 4

Apolipoprotein E R112; R251G: a carboxy-terminal variant found in patients with hyperlipidemia and coronary heart disease

Kang, A. K., Jenkins, D. J. A., Wolever, T. M. S., Huff, M. W., Maguire, G. F., Connelly, P. W., & Hegele, R. A. (1997) · Mutation Research/Mutation Research Genomics · doi:10.1016/s1383-5726(97)00009-5 · Cited by 4

Lipoproteins: A Source of Cardiac Lipids

Drosatos, K., & Goldberg, I. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1227-8_2 · Cited by 4

Cholesterol and Alzheimer’s Disease

Cordy, J. M., & Wolozin, B. L. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_9 · Cited by 4

Correction: In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS

Wildsmith, K. R., Basak, J. M., Patterson, B. W., Pyatkivskyy, Y., Kim, J., Yarasheski, K. E., Wang, J. X., Mawuenyega, K. G., Jiang, H., Parsadanian, M., et al. (2012) · PLoS ONE · doi:10.1371/annotation/9bd329b7-cdea-45ec-a4aa-a173855dc0b9 · Cited by 4

Structural variation manipulates the differential oxidative susceptibility and conformational stability of apolipoprotein E isoforms

Su, K., Wen, T., Chou, C., Chang, G., Liu, G., & Hung, H. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21443 · Cited by 3

APOE Isoform-Dependent Self-Association Measured by a Split-Luciferase Complementation Assay: Differential Effects of Disease-Risk and Protective Variants

Andrieieva, D., Falltrick, I., Chiang, C.-Y., Beaumont, B., Guen, Y. L., Liu, C., Pergolesi, S., Ma, C.-T., Jackson, M. R., Hyman, B. T., et al. (2026) · doi:10.64898/2026.05.09.26352797 · Cited by 2

Apolipoprotein E polymorphism and dyslipidemia in Thais

Decharatkulchai, N., Settasatian, C., Settasatian, N., Komanasin, N., Leelayuwat, N., Sirijaichingkul, S., Teerajetgul, Y., & Changtrakun, D. (2009) · Archives of Allied Health Sciences · Cited by 2

Whole Eggs: The Magic Bullet?

Queen, H. L. S. (2002) · doi:10.1002/9780470376973.ch14 · Cited by 2

Apolipoprotein E: Paradoxes Abound

Hazzard, W. R., Applebaum-Bowden, D. M., & Terry, J. G. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1959-1_8 · Cited by 2

Roles of the Apolipoprotein E Gene and Its Polymorphisms in the Etiopathophysiology of Type 2 Diabetes Mellitus and Its Atherosclerotic Complication in Senegalese Females

Touré, M., Agne, F. D., Dieng, A., Diallo, R. N., Guéye, L., & Samb, A. (2023) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2023.134023 · Cited by 1

Apolipoprotein-ε4 (APOE) Gene Is a Risk Factor for Human Coronary Artery Disease

Hazarika, L., & Sen, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_61-1 · Cited by 1

From genetic roots to recent advancements in gene therapy targeting amyloid beta in Alzheimer’s disease

Peyvand, P., Allami, P., & Rezaei, N. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2025-0025 · Cited by 1

Impact of a high-fat diet on spatial learning and memory: The role of sex, APOE genotype, and postnatal chlorpyrifos exposure

Guardia-Escote, L., Biosca-Brull, J., Blanco, J., Cabré, M., Basaure, P., Pérez-Fernández, C., Sánchez-Santed, F., Domingo, J. L., & Colomina, M. T. (2025) · NeuroToxicology · doi:10.1016/j.neuro.2025.07.004 · Cited by 1

Role of Apolipoprotein E in Alzheimer’s Disease: Clues from its Structure

Weisgraber, K. H., & Dong, L. (1996) · Springer eBooks · doi:10.1007/978-3-642-80109-9_2 · Cited by 1

Vascular Inflammation and Genetic Predisposition as Risk Factors for Cardiovascular Diseases

Gungor, Z. B. (2018) · InTech eBooks · doi:10.5772/intechopen.76016 · Cited by 1

Apolipoprotein E and Reverse Cholesterol Transport: The Role of Recycling in Plasma and Intracellular Lipid Trafficking

Swift, L. L., Hasty, A. H., Linton, M. F., & Fazio, S. (2007) · Wiley eBooks · doi:10.1002/9783527625178.ch3 · Cited by 1

Postprandial redistribution of apo E isoforms in triglyceride-rich lipoproteins

Richter, G., Schwarz, S., Manthey, T., Ehlenz, K., Kaffarnik, H., & Steinmetz, A. (1993) · Vieweg+Teubner eBooks · doi:10.1007/978-3-663-01942-8_12 · Cited by 1

Potential Biological Mechanisms of ApoE in Alzheimer’s Disease

Rebeck, G. W. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_2 · Cited by 1

APOE Impacts Lipid Trafficking in Retinal Pigment Epithelium CellsPreprint

Richards, S. E. V., Demirs, J. T., Jose, S., Fan, L., Xu, Y., Esterberg, R., Huang, C. L., Wilson, C. W., Saint‐Geniez, M., & Liao, S.-M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.30.596647 · Cited by 1

Effect of Apo (E-AII) Complex Concentration on Serum Lipids

Tozuka, M., Hidaka, H., Miyachi, M., Katsuyama, T., & Kanai, M. (1992) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.20.6-7_563 · Cited by 1

APOLIPOPROTEÍNA E Y ENFERMEDAD CARDIOVASCULAR

Valladares, A. M., Perdomo, Á. E. C., & Pabón, G. M. (2006) · DOAJ (DOAJ: Directory of Open Access Journals)

Regulierung und Verfügbarkeit von Apolipoprotein E in Astrozyten

Hamker, U. (2005) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15272

Genetic Factors Contributing to Cardiovascular Disease that may affect Endothelial Structure and Function: The Role of Proteins involved in Lipoprotein Transport

Zannis, V. I., Laccotripe, M., Makrides, S. C., Kardassis, D., & Zanni, E. E. (1996) · Springer eBooks · doi:10.1007/978-1-4613-0355-8_7

Bedeutung des LDL-Rezeptor-Related Protein 1 für den zellulären Stoffwechsel der ApoE-Isoformen

Beisiegel†, U. (2007)

Apolipoprotein E gene polymorphism in Greek children with nephrotic syndrome

Papadopoulou, V., Makedou, K., Papadopoulou, D., Argyriou, A., Gatzola, M., & Hitoglou, A. (2013) · Aristotle University Medical journal/Aristotle University Medical Journal

The genetic contribution to the onset of acute coronary heart disease

Cambien, F., Poirier, O., Evans, A., Arveiler, D., Luc, G., Cambou, J., & Tiret, L. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-009-1577-0_8

Association of Apolipoprotein E Genotype with Early and Advanced Atherosclerotic Lesions

Ilveskoski, E. (2001) · Tampere University Institutional Repository (Tampere University)

In-vivo Metabolismus der VLDL-Apolipoproteine ApoB, ApoCIII und ApoE Turn-over Untersuchungen zum Apolipoprotein-Stoffwechsel unter Verwendung von mit stabilen Isotopen markierten Aminosäuren als Tracer

München, K. D. L.-M.-U. (2002)

Type III hyperlipoproteinaemia

(2007) · CRC Press eBooks · doi:10.1201/b13464-8

The Purification and Identification of Interactors to Elucidate Novel Connections in the HEK 293 Cell Line

Hawley, B. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-6225

The role of apolipoprotein E in traumatic brain injury as determined by isoform and Abca1 haplodeficiency

Castranio, E. L. (2018) · D-Scholarship@Pitt (University of Pittsburgh)

Modelling the neurobiology of Alzheimer’s disease in vitro

Muñoz, S. S. (2019) · Research Online (University of Wollongong)

Efecto del polimorfismo genético de la aplipoproteina e y del consumo de una muestra alimenticia de galletas preparados con aceite de palma con concentraciones diferenciales en contenidos de tocotrienoles, sobre las variaciones del perfil lipídico en preescolares de la ciudad de Bogotá D.C.

Herrera, C. M., & Luís, J. (2013)

Genetic Determinants of Human Longevity

Dato, S., Soerensen, M., & Rose, G. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-679-6

1 H, 15 N and 13 C chemical shift assignments of the N-terminal domain of the two isoforms of the human apolipoprotein E

Pandit, S. (2022) · Biomolecular NMR Assignments · doi:10.1007/s12104-022-10078-3

Conformational Dynamics in Risk and Resilience Alleles of Apolipoprotein E (APOE) for Alzheimer's DiseasePreprint

Martin, W., & Cheng, F. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4705580

In Silico Design of APOE ɛ4 Interaction Inhibitor Peptides for Alzheimer’s DiseasePreprint

Ji, J., Han, E., Park, J., Son, A., & Kim, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.03.673973

ApoE and Gut Microbiome

Smith, C. J., & Perfetti, T. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_18-1

Putative Survival Advantages in Infant, Child, and Young Adult Apolipoprotein ε4 Carriers

Smith, C. J., Ashford, J. W., & Perfetti, T. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_13-1

APOE, Biomarkers, and Proteogenomics in Alzheimer’s Disease

Pereira, J. D., Tosatti, J. A. G., & Gomes, K. B. (2026) · Springer eBooks · doi:10.1007/978-3-031-52641-1_66-1

APOE Gene Editing as a Therapeutic Target Toward Precision Medicine in AD

Teter, B., Campagna, J. J., Spilman, P. R., & John, V. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_73-1 · Cited by 1

Apolipoprotein E, malnutrition, and neurodegenerative risk

Ciurleo, G. C. V., Carvalho, C. G. M., Freitas, R. S., & Oriá, R. B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33841-0.00032-4

Association between serum lipid-apolipoprotein alterations and soluble syndecan-1 dynamics in sepsis: impact of apolipoprotein E isoforms

Shimizu, R., Akahane, S., Suzuki, H., Matsuura, H., Uematsu, Y., Iimura, W., Ishimine, N., & Yamauchi, K. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102634

APOE, Biomarkers, and Proteogenomics in Alzheimer’s Disease

Pereira, J. D., Tosatti, J. A. G., & Gomes, K. B. (2026) · Springer eBooks · doi:10.1007/978-3-031-96089-5_66

APOE Gene Editing as a Therapeutic Target Toward Precision Medicine in AD

Teter, B., Campagna, J. J., Spilman, P., & John, V. (2026) · Springer eBooks · doi:10.1007/978-3-031-96089-5_73

A role for apolipoprotein E4 (ApoE4) in the pathogenesis of depressive symptoms and Alzheimer’s disease

Lu, Q.-X., & Guan, W. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118316

17α-Estradiol Confers Limited Protection Against APOE4 Phenotypes in Middle-Aged Female MicePreprint

McGill, C. J., Christensen, A., Namvari, S., Thorwald, M. A., Anson, H., Vermulst, M., Finch, C. E., Benayoun, B. A., & Pike, C. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.06.743074

Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins

Steinmetz, A., Jakobs, C., Motzny, S., & Kaffarnik, H. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.3.405 · Cited by 93

Human apolipoprotein E: Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms

Dong, L. M., Wilson, C., Wardell, M. R., Simmons, T., Mahley, R. W., Weisgraber, K. H., & Agard, D. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31797-0 · Cited by 320

Molecular Mechanisms Responsible for the Differential Effects of ApoE3 and ApoE4 on Plasma Lipoprotein–Cholesterol Levels

Li, H., Dhanasekaran, P., Alexander, E. T., Rader, D. J., Phillips, M. C., & Lund‐Katz, S. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301193 · Cited by 73

Apolipoprotein E isoforms and lipoprotein metabolism

Phillips, M. C. (2014) · IUBMB Life · doi:10.1002/iub.1314 · Cited by 328

Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.

Rall, S. C., Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.15.4696 · Cited by 345